STOCK TITAN

MiMedx To Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

MiMedx Group has announced that CEO Timothy R. Wright and CFO Peter M. Carlson will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference happening from December 1-3, 2020. A pre-recorded presentation will be available on the company's website starting November 25, 2020, at 5:00 PM Eastern Time, and will be accessible for 45 days. MiMedx specializes in advanced wound care and therapeutic biologics, particularly using PURION technology to produce human placental tissue allografts, having supplied over 2 million allografts to date.

Positive
  • None.
Negative
  • None.

MARIETTA, Ga., Nov. 24, 2020 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place December 1-3, 2020.

A pre-recorded presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com beginning on November 25, 2020 at 5:00 PM Eastern Time and will be accessible for approximately 45 days.

About MiMedx
MiMedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied more than two million allografts, through both direct and consignment shipments. For additional information, please visit www.mimedx.com.

Contact
Hilary Dixon
Investor Relations & Corporate Communications
770.651.9066
investorrelations@mimedx.com


FAQ

When is MiMedx presenting at the Piper Sandler Virtual Healthcare Conference?

MiMedx will present at the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1-3, 2020.

Who are the presenters from MiMedx at the conference?

The presenters from MiMedx are CEO Timothy R. Wright and CFO Peter M. Carlson.

Where can I access MiMedx's presentation?

MiMedx's pre-recorded presentation will be available on their website starting November 25, 2020, at 5:00 PM ET.

How long will the MiMedx presentation be available for viewing?

The MiMedx presentation will be accessible for approximately 45 days after its release.

What products does MiMedx specialize in?

MiMedx specializes in advanced wound care and therapeutic biologics, particularly human placental tissue allografts.

How many allografts has MiMedx supplied?

MiMedx has supplied more than 2 million allografts through various distribution methods.

MiMedx Group, Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Stock Data

1.34B
143.03M
2.45%
68.17%
2.4%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States of America
MARIETTA